omniture
Samsung Biologics Co. Ltd.

Latest News

Samsung Biologics Reports First Quarter 2021 Financial Results

* Q1'21 revenue of KRW 260.8 billion increased 26% compared to Q1'20. * Q1'21 operating profit o...

2021-04-28 16:37 3493

Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life."

INCHEON, South Korea, April 21, 2021 /PRNewswire/ -- Samsung Biologics, the world's leading contrac...

2021-04-21 19:00 551

Samsung Biologics Unveils Strong Performance and Future Plans at its 10th Annual General Meeting of Shareholders

INCHEON, South Korea, March 18, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced a...

2021-03-19 09:49 4038

Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA

INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced an...

2021-01-27 08:26 5139

Samsung Biologics Reports 66% Increase in 2020 Revenue Achieving "1 Trillion Won" Target Sales

INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) reported its...

2021-01-26 15:00 5432

Samsung Biologics Shares 'Vision' for Next Decade at the 39th Annual JP Morgan Healthcare Conference

INCHEON, South Korea, Jan. 13, 2021 /PRNewswire/ -- Samsung Biologics (207940.KS) set forth its dyn...

2021-01-13 23:17 6660

Samsung Biologics Names John Rim as President and CEO

INCHEON, South Korea, Dec. 16, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announcedJoh...

2020-12-16 20:00 744

Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch

INCHEON, South Korea, Dec. 4, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced the...

2020-12-04 20:00 1600

Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility

INCHEON, South Korea, Nov. 18, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) officially b...

2020-11-18 20:00 788

Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments

INDIANAPOLIS and INCHEON, South Korea, Nov. 17, 2020 /PRNewswire/ -- Samsung Biologics' partnership...

2020-11-17 20:00 753

Samsung Biologics' Virtual Exhibition Hall earns top industry award for digital creativity and innovation

INCHEON, South Korea, Oct. 4, 2020 /PRNewswire/ -- Samsung Biologics' Virtual Exhibition Hall was r...

2020-11-04 20:00 928

Samsung Biologics and Checkpoint Therapeutics Expand Manufacturing Partnership for Cosibelimab

INCHEON, South Korea and NEW YORK, Nov. 2, 2020 /PRNewswire/ -- Samsung Biologics Co., Ltd. ("Samsu...

2020-11-02 20:00 3474

Samsung Biologics Establishes Partnership with China Biotech GeneQuantum Healthcare to Collaborate on ADC Development

INCHEON, South Korea and SUZHOU, China, Nov. 1, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) ...

2020-11-02 08:27 668

Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center

INCHEON, South Korea and SAN FRANCISCO, Oct. 28, 2020 /PRNewswire/ -- At a virtual ceremony today, ...

2020-10-29 08:38 5711

Samsung Biologics' strategic business operations continue to support strong third quarter earnings

INCHEON, South Korea, Oct. 21, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) maintained s...

2020-10-21 19:00 7288

Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment

INCHEON, South Korea, Oct. 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into ...

2020-10-20 19:00 8304

Samsung Biologics partners with BioEleven for cancer immunotherapy development and manufacturing

INCHEON, South Korea, Oct. 19, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into ...

2020-10-19 19:00 8925

Samsung Biologics signs strategic partnership with Kanaph Therapeutics to develop treatment for retinal diseases

INCHEON, South Korea, Sept. 23, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and Kanaph Thera...

2020-09-24 08:00 848

Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply

INCHEON, South Korea, Sept. 21, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and AstraZeneca ...

2020-09-22 07:00 11725

Samsung Biologics signs development agreement with Panolos for solid tumor treatment

INCHEON, South Korea, Sept. 16, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into...

2020-09-17 08:43 1189
123